Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ATAD2 mRNA | decreases expression | 20106945 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of ATAD2 mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATAD2 mRNA | decreases expression | 20382639 19150397
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of ATAD2 mRNA | increases expression | 16474171
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA | decreases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ATAD2 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of ATAD2 mRNA | increases expression | 16474171
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA | affects cotreatment|increases expression | 17404688
|
D019833 |
Genistein |
Genistein results in increased expression of ATAD2 mRNA | increases expression | 16474171
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of ATAD2 mRNA | increases expression | 20713471
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATAD2 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ATAD2 mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATAD2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of ATAD2 mRNA | increases expression | 16474171
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of ATAD2 mRNA | increases expression | 17404688
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA | decreases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of ATAD2 mRNA | decreases expression | 16249480
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.57 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.57 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.17 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.17 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.17 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
7.17 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.97 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
6.97 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
17.79 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.79 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.79 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.11 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.48 | 11922910 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.60 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.60 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.60 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.92 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.43 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.33 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.78 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.78 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.78 | 12948864 17261762 17018787 16675129 17289903 19861407 18497071 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
4.78 | 17200150 16541309 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
4.78 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
4.78 | 17614352 16175315 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.78 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.78 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.55 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.48 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.48 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.66 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
6.66 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
6.66 | 17173139 20007298 1701930 6705139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.66 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.07 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.62 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.62 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.34 | 16332659 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.12 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.35 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
16.35 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
16.35 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
16.35 | 16192471 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.32 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.89 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.89 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.83 | 12621046 8697196 15340226 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.83 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.29 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
2.73 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.46 | 8800419 10589399 9664655 17551590 9125849 16925845 9211117 9142499 9224671 14991402 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.75 | 16140633 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.45 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.37 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.37 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.46 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.56 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.55 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.06 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.72 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.72 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.27 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.27 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.84 | 17692515 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.67 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.67 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
12.67 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.67 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.10 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.10 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.18 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.97 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.91 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.59 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.32 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.10 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.39 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.39 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.97 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.97 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.74 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.74 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.02 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.16 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.16 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
15.16 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.32 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.32 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.22 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.25 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.25 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.25 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.57 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
14.82 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.82 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.82 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.13 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.85 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 16959395 16354765 8697196 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.25 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.23 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.01 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.01 | 18850075 18670907 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.47 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.07 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.07 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.52 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.52 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.52 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.12 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.12 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.04 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.04 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.42 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.42 | 15610895 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.50 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.50 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.75 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.19 | 17217047 19075265 17294898 16788101 9834237 19029980 16140955 19225113 17339181 12679006 17649720 17361223 16891316 17506722 16823087 17368321 19642359 17301526 17712046 16935935 19035177 16766008 17107899 15748426 16331271 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.92 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.79 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.79 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.79 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.79 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.79 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.18 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.83 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
10.83 | 15975961 8742319 19073162 19812893 21047994 19482888 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.83 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.83 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
14.47 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
14.47 | 18308698 1399818 6150874 2563599 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
14.47 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.47 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.46 | 18520028 18816296 20064080 18569708 20869020 20464547 17053015 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
3.46 | 9230183 21163286 16271038 11893704 20970405 17909032 7750092 6695378 1399818 20512841 10545420 15390079 16337739 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.46 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.22 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
10.22 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.22 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.58 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.95 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.23 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.58 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.11 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.75 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.75 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
14.42 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
14.42 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
14.42 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.56 | 17484760 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.34 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.34 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.34 | 16946489 16594593 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.81 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.33 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
31.51 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
31.51 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
31.51 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
31.51 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
31.51 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.09 | 9142499 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.45 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.28 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.14 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.07 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.44 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.44 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.44 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.44 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.34 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.34 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.41 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.13 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.13 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.79 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.79 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.74 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.74 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.87 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.87 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.87 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.87 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
1.87 | 15721890 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.66 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.59 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.87 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.41 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.16 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.87 | 18045962 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.73 | 4039156 3137016 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.90 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.75 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.75 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.75 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.75 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.36 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.36 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.36 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.07 | 16045194 16684133 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
7.33 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.33 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.78 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.84 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.20 | 17053015 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.73 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.11 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.71 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.12 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |